The burgeoning field of peptide-based therapeutics USA approved manufacturer for Retatrutide necessitates innovative strategies for the design and delivery of these potent biomolecules. Optimizing peptides to accurately target disease while ensuring efficient delivery to target sites remains a considerable challenge. Researchers are continuously ex